{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:52:26Z","timestamp":1781610746438,"version":"3.54.5"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and method<\/jats:title>\n                    <jats:p>Between 01.01.2016 \u2013 31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/rjim-2025-0016","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:46:12Z","timestamp":1758257172000},"page":"265-276","source":"Crossref","is-referenced-by-count":0,"title":["Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center"],"prefix":"10.2478","volume":"63","author":[{"given":"Larisa Renata","family":"Pantea-Ro\u0219an","sequence":"first","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"},{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy , University of Oradea , Oradea , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"\u021aica","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Oradea, Pathology Department , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"},{"name":"Department of Morphological Disciplines, Faculty of Medicine and Pharmacy , , Oradea , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otilia Anca","family":"\u021aica","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Ioachim","family":"Popescu","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"},{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy , University of Oradea , Oradea , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Buzle","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0103d\u0103lina Ioana","family":"Moisi","sequence":"additional","affiliation":[{"name":"Emergency County Clinical Hospital of Bihor, Cardiology Clinic , Gheorghe Doja Street, no. 65 , Oradea, Bihor County , Romania"},{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy , University of Oradea , Oradea , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad Alin","family":"Pantea","sequence":"additional","affiliation":[{"name":"Department of Dental Medicine, Faculty of Medicine and Pharmacy , University of Oradea , Oradea , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026061610553127557_j_rjim-2025-0016_ref_001","doi-asserted-by":"crossref","unstructured":"ALABAS O.A., JERNBERG T., PUJADES-RODRIGUEZ M., RUTHERFORD M.J., WEST R.M., HALL M., TIMMIS A., LINDAHL B., FOX K.A.A., HEMINGWAY H., GALE C.P. Statistics on mortality following acute myocardial infarction in 842,897 Europeans. Cardiovasc Res. 2020; 116(1):149\u2013157.","DOI":"10.1093\/cvr\/cvz197"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_002","doi-asserted-by":"crossref","unstructured":"THYGESEN K., ALPERT J.S., JAFFE A.S., CHAITMAN B.R., BAX J.J., MORROW D.A., WHITE H.D. AND THE EXECUTIVE GROUP ON BEHALF OF THE JOINT EUROPEAN SOCIETY OF CARDIOLOGY (ESC)\/AMERICAN COLLEGE OF CARDIOLOGY (ACC)\/AMERICAN HEART ASSOCIATION (AHA)\/WORLD HEART FEDERATION (WHF) TASK FORCE FOR THE UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018; 138(20):e618\u2013e65.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_003","unstructured":"ASHRAF T., KHAN M.N., AFAQUE S.M., AAMIR K.F., KUMAR M., SAGHIR T., RASOOL S.I., et al. Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention. Int J Cardiol. 2019; pii: S0167-5273(19)32691-9."},{"key":"2026061610553127557_j_rjim-2025-0016_ref_004","unstructured":"TATU-CHI\u021aOIU G., TATU-CHI\u021aOIU A., L\u0102C\u0102U S. Electrocardiograma \u00een reperfuzia miocardic\u0103. Bucure\u0219ti (RO): Edit. Medical\u0103 Antaeus; 2014."},{"key":"2026061610553127557_j_rjim-2025-0016_ref_005","doi-asserted-by":"crossref","unstructured":"NAIR RAJESH G., JAYAPRASAD N., MADHAVAN S., SUDHA KUMARY V., JAYAPRAKASH K., et al. Predictors and prognosis of no-reflow during primary percutaneous coronary intervention. Proc (Bayl Univ Med Cent). 2018; 32(1):30\u201333.","DOI":"10.1080\/08998280.2018.1509577"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_006","doi-asserted-by":"crossref","unstructured":"AL AZZONI A.M., LAMELAS P., MARSDEN T., DZAVIK V., CAIRNS J., MEEKS B., et al. Incidence and predictors of no reflow phenomenon: insights from the total trial. Journal of the American College of Cardiology. 2017; 69(11); Suppl1179.","DOI":"10.1016\/S0735-1097(17)34568-0"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_007","doi-asserted-by":"crossref","unstructured":"IBANEZ B., JAMES S., AGEWALL S., ANTUNES M.J., BUCCIARELLI-DUCCI C., BUENO H., et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2):119\u2013177.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_008","doi-asserted-by":"crossref","unstructured":"HARRISON R.W., AGGARWAL A., OU F.S., KLEIN L.W., RUMSFELD J.S., ROE M.T., WANG T.Y. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178\u201384.","DOI":"10.1016\/j.amjcard.2012.09.015"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_009","doi-asserted-by":"crossref","unstructured":"NICCOLI G., COSENTINO N., SPAZIANI C., FRACASSI F., TARANTINI G., CREA F. No-reflow: incidence and detection in the cath-lab. Curr Pharm Des. 2013;19(25):4564\u201375.","DOI":"10.2174\/1381612811319250005"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_010","doi-asserted-by":"crossref","unstructured":"SINUSAS A.J. Noninvasive Evaluation of No-Reflow Phenomenon. Circulation: Cardiovascular Imaging. 2018; 11(11):e008576.","DOI":"10.1161\/CIRCIMAGING.118.008576"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_011","doi-asserted-by":"crossref","unstructured":"VEROUDEN N.J., HAECK J.D., KOCH K.T., HENRIQUES J.P., BAAN J., VAN DER SCHAAF R.J., et al. ST-segment resolution prior to primary percutaneous coronary intervention is a poor indicator of coronary artery patency in patients with acute myocardial infarction. Ann Noninvasive Electrocardiol. 2010;15(2):107\u201315.","DOI":"10.1111\/j.1542-474X.2010.00350.x"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_012","doi-asserted-by":"crossref","unstructured":"OIKONOMOU E., MOUROUZIS K., VOGIATZI G., SIASOS G., DEFTEREOS S., PAPAIOANNOU S., et al. Coronary Microcirculation and the No-reflow Phenomenon. Curr Pharm Des. 2018;24(25):2934\u20132942.","DOI":"10.2174\/1381612824666180911122230"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_013","doi-asserted-by":"crossref","unstructured":"ITO H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3(9):499\u2013506.","DOI":"10.1038\/ncpcardio0632"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_014","doi-asserted-by":"crossref","unstructured":"BOULETI C., MEWTON N., GERMAIN S. The no-reflow phenomenon: State of the art. Arch Cardiovasc Dis. 2015;108(12):661\u201374.","DOI":"10.1016\/j.acvd.2015.09.006"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_015","doi-asserted-by":"crossref","unstructured":"HARRISON R.W., AGGARWAL A., OU F.S., KLEIN L.W., RUMSFELD J.S., ROE M.T., WANG T.Y. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178\u201384.","DOI":"10.1016\/j.amjcard.2012.09.015"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_016","doi-asserted-by":"crossref","unstructured":"JYOTSNA M., NEMANI L. No-Reflow. Ind J Car Dis Wom. 2017; 02(01): 082\u2013098.","DOI":"10.1055\/s-0038-1656464"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_017","doi-asserted-by":"crossref","unstructured":"HUTCHINS K.D., SKURNICK J., LAVENHAR M., NATARAJAN G.A. Cardiac rupture in acute myocardial infarction: a reassessment. Am J Forensic Med Pathol. 2002;23(1):78\u201382.","DOI":"10.1097\/00000433-200203000-00017"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_018","doi-asserted-by":"crossref","unstructured":"UENO D., NOMURA T., ONO K., SAKAUE Y., HORI Y., YOSHIOKA K., KIKAI M., KEIRA N., TATSUMI T. Fatal Right Ventricular Free Wall Rupture During Percutaneous Coronary Intervention for Inferior Acute Myocardial Infarction. Am J Case Rep. 2019;20:1155\u20131158.","DOI":"10.12659\/AJCR.917217"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_019","doi-asserted-by":"crossref","unstructured":"AZEVEDO P.S., POLEGATO B.F., MINICUCCI M.F., PAIVA S.A.R., ZORNOFF L.A.M. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2016; 106(1): 62\u201369.","DOI":"10.5935\/abc.20160005"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_020","doi-asserted-by":"crossref","unstructured":"FRENCH B.A., KRAMER C.M. Mechanisms of Post-Infarct Left Ventricular Remodeling. Drug Discov Today Dis Mech. 2007; 4(3): 185\u2013196.","DOI":"10.1016\/j.ddmec.2007.12.006"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_021","doi-asserted-by":"crossref","unstructured":"MORISHIMA I., SONE T., OKUMURA K., TSUBOI H., KONDO J., MUKAWA H., MATSUI H., TOKI Y., ITO T., HAYAKAWA T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36(4):1202\u20139.","DOI":"10.1016\/S0735-1097(00)00865-2"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_022","doi-asserted-by":"crossref","unstructured":"YONG A.S.C., FEARON W.F. Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2018; 7(15): e009828.","DOI":"10.1161\/JAHA.118.009828"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_023","doi-asserted-by":"crossref","unstructured":"ARMSTRONG R., DE MARIA G.L., SCARSINI R., BANNING A.P. Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction. Expert Rev Cardiovasc Ther. 2019;17(2):111\u2013126.","DOI":"10.1080\/14779072.2019.1561279"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_024","doi-asserted-by":"crossref","unstructured":"YONG A.S., FEARON W.F. Coronary microvascular dysfunction after ST-segment-elevation myocardial infarction: local or global phenomenon?. Circ Cardiovasc Interv. 2013;6(3):201\u20133.","DOI":"10.1161\/CIRCINTERVENTIONS.113.000462"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_025","doi-asserted-by":"crossref","unstructured":"BEKKERS S.C., YAZDANI S.K., VIRMANI R., WALTENBERGER J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol. 2010;55(16):1649\u201360.","DOI":"10.1016\/j.jacc.2009.12.037"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_026","doi-asserted-by":"crossref","unstructured":"SCHWARTZ R.S., BURKE A., FARB A., KAYE D., LESSER J.R., HENRY T.D., VIRMANI R. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009;54(23):2167\u201373.","DOI":"10.1016\/j.jacc.2009.07.042"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_027","doi-asserted-by":"crossref","unstructured":"REINDL M., REINSTADLER S.J., FEISTRITZER H.J., KLUG G., TILLER C., MAIR J., MAYR A., JASCHKE W., METZLER B. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017;6(7):640\u201364.","DOI":"10.1177\/2048872616661691"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_028","doi-asserted-by":"crossref","unstructured":"VRINTS C.J. Pathophysiology of the no-reflow phenomenon. Acute Card Care. 2009;11(2):69\u201376.","DOI":"10.1080\/17482940902978061"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_029","doi-asserted-by":"crossref","unstructured":"NICCOLI G., SCALONE G., LERMAN A., CREA F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024\u201333.","DOI":"10.1093\/eurheartj\/ehv484"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_030","doi-asserted-by":"crossref","unstructured":"ITO H. Etiology and clinical implications of microvascular dysfunction in patients with acute myocardial infarction. Int Heart J. 2014;55(3):185\u20139.","DOI":"10.1536\/ihj.14-057"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_031","doi-asserted-by":"crossref","unstructured":"BELTRAME J.F. Coronary microvascular dysfunction in acute ST elevation myocardial infarction. Coronary Artery Disease. 2017; 28(1):3\u20134.","DOI":"10.1097\/MCA.0000000000000443"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_032","doi-asserted-by":"crossref","unstructured":"KHAN J.N., RAZVI N., NAZIR S.A., SINGH A., MASCA N.G., GERSHLICK A.H., SQUIRE I., MCCANN G.P. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2014;16:38.","DOI":"10.1186\/1532-429X-16-38"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_033","doi-asserted-by":"crossref","unstructured":"NICCOLI G., SCALONE G., LERMAN A., CREA F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024\u201333.","DOI":"10.1093\/eurheartj\/ehv484"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_034","doi-asserted-by":"crossref","unstructured":"NAGAO M., HIGASHINO H., MATSUOKA H., KAWAKAMI H., MOCHIZUKI T., MURASE K., UEMURA M., KOUNO T. Clinical importance of microvascular obstruction on contrast-enhanced MRI in reperfused acute myocardial infarction. Circ J. 2008;72(2):200\u20134.","DOI":"10.1253\/circj.72.200"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_035","doi-asserted-by":"crossref","unstructured":"THYGESEN K. What\u2019s new in the Fourth Universal Definition of Myocardial infarction? Eur Heart J. 2018;39(42):3757\u20133758.","DOI":"10.1093\/eurheartj\/ehy655"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_036","doi-asserted-by":"crossref","unstructured":"LEE C.H., WONG H.B., TAN H.C., ZHANG J.J., TEO S.G., ONG H.Y., LOW A., SUTANDAR A., LIM Y.T. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for ate myocardial infarction-insights from a 1328 patient registry. J Interv Cardiol. 2005;18(4):261\u20136.","DOI":"10.1111\/j.1540-8183.2005.00041.x"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_037","doi-asserted-by":"crossref","unstructured":"ALABAS O.A., GALE C.P., HALL M., RUTHERFORD M.J., SZUMMER K., LAWESSON S.S., ALFREDSSON J., LINDAHL B., JERNBERG T. Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry. J Am Heart Assoc. 2017;6(12). pii: e007123.","DOI":"10.1161\/JAHA.117.007123"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_038","doi-asserted-by":"crossref","unstructured":"SMILOWITZ N.R., MAHAJAN A.M., ROE M.T., HELLKAMP A.S., CHISWELL K., GULATI M., REYNOLDS H.R. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines). Circ Cardiovasc Qual Outcomes. 2017;10(12):e003443.","DOI":"10.1161\/CIRCOUTCOMES.116.003443"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_039","doi-asserted-by":"crossref","unstructured":"SCHOLZ K.H., MAIER S.K.G., MAIER L.S., LENGENFELDER B., JACOBSHAGEN C., JUNG J., et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065\u20131074.","DOI":"10.1093\/eurheartj\/ehy004"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_040","doi-asserted-by":"crossref","unstructured":"KARWOWSKI J., GIERLOTKA M., G\u0104SIOR M., POLO\u0143SKI L., CISZEWSKI J., B\u0118\u0106KOWSKI M., KOWALIK I., SZWED H. Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients. Pol Arch Intern Med. 2017;127(6):401\u2013411.","DOI":"10.20452\/pamw.4018"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_041","doi-asserted-by":"crossref","unstructured":"CHOO E.H., KIM P.J., CHANG K., AHN Y., JEON D.S., LEE J.M., et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron Artery Dis. 2014;25(5):392\u20138.","DOI":"10.1097\/MCA.0000000000000108"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_042","doi-asserted-by":"crossref","unstructured":"KIM M.C., CHO J.Y., JEONG H.C., LEE K.H., PARK K.H., SIM D.S., et al. Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. Korean Circ J. 2016;46(4):490\u20138.","DOI":"10.4070\/kcj.2016.46.4.490"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_043","doi-asserted-by":"crossref","unstructured":"JIECHENG P., AI-LING W. Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions. Perfusion. 2016;31(4):300\u20136.","DOI":"10.1177\/0267659115604891"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_044","doi-asserted-by":"crossref","unstructured":"BADIMON L., VILAHUR G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618\u201332.","DOI":"10.1111\/joim.12296"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_045","doi-asserted-by":"crossref","unstructured":"KAUL S. The \u201cno reflow\u201d phenomenon following acute myocardial infarction: mechanisms and treatment options. J Cardiol. 2014; 64(2):77\u201385.","DOI":"10.1016\/j.jjcc.2014.03.008"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_046","doi-asserted-by":"crossref","unstructured":"PASOTTI M., PRATI F., ARBUSTINI E. The pathology of myocardial infarction in the pre- and post-interventional era. Heart. 2006; 92(11):1552\u20136.","DOI":"10.1136\/hrt.2005.086934"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_047","doi-asserted-by":"crossref","unstructured":"BISOYI S., DASH A.K., NAYAK D., SAHOO S., MOHAPATRA R. Left ventricular pseudoaneurysm versus aneurysm a diagnosis dilemma. Ann Card Anaesth. 2016; 19(1):169\u201372.","DOI":"10.4103\/0971-9784.173042"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_048","doi-asserted-by":"crossref","unstructured":"ISKHAKOV M.M., TAGIROVA D.R., GAZIZOV N.V., NUGAYBEKOVA L.A., SAYFUTDINOV R.G. No-reflow phenomenon: clinical aspects of reperfusion failure. Kazan Medical Journal 2015; 96(3):391\u2013396.","DOI":"10.17750\/KMJ2015-391"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_049","doi-asserted-by":"crossref","unstructured":"PANTEA-ROSAN L.R., PANTEA V.A., BUNGAU S., TIT D.M., BEHL T., VESA C.M., et al. No-reflow after PPCI \u2013 A predictor of short-term outcomes in STEMI patients. Journal of Clinical Medicine, 2020; 9(9):1\u201316.","DOI":"10.3390\/jcm9092956"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_050","doi-asserted-by":"crossref","unstructured":"SHAMSHAD F., KENCHAIAH S., FINN P.V., SOLER-SOLER J., MCMURRAY J.J., VELAZQUEZ E.J., MAGGIONI A.P., et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010;160(1):145\u201351.","DOI":"10.1016\/j.ahj.2010.02.037"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_051","doi-asserted-by":"crossref","unstructured":"\u021aICA O., \u021aICA O., BUNTING K.V., DEBONO J., GKOUTOS G.V., POPESCU M.I., KOTECHA D. Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation. BMC Med. 2022; 20(1):331.","DOI":"10.1186\/s12916-022-02533-8"},{"key":"2026061610553127557_j_rjim-2025-0016_ref_052","doi-asserted-by":"crossref","unstructured":"JELAVIC M.M., \u021aICA O., PINTARIC H., \u021aICA O. Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation. Cardiology. 2023; 148(6):593\u2013595.","DOI":"10.1159\/000533880"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2025-0016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:05:56Z","timestamp":1781607956000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2025-0016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.2478\/rjim-2025-0016"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2025-0016","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}